SCHEDULE: BlackRock Reports 5.1% Stake in Anterix Inc.

BlackRock, Inc. has reported an updated beneficial ownership of 5.1% in Anterix Inc., holding 950,842 shares of common stock as of September 30, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 2 to Schedule 13G for Anterix Inc.
• As of September 30, 2025, BlackRock beneficially owned 950,842 shares of Anterix Inc. common stock.
• This represents 5.1% of the total outstanding common stock of Anterix Inc.
• BlackRock holds sole voting power over 937,619 shares and sole dispositive power over 950,842 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Anterix Inc.
• Several BlackRock subsidiaries, including BlackRock Advisors, LLC and BlackRock Fund Advisors, are involved in the beneficial ownership, with at least one entity owning 5% or greater of the outstanding shares.

Sentiment

Score: 7

Explanation: The filing indicates a significant and stable institutional investment by BlackRock, a positive signal of confidence in Anterix Inc. from a major asset manager. There are no negative disclosures within the filing itself.

Positives

• A major institutional investor, BlackRock, maintains a significant stake (5.1%) in Anterix Inc., indicating continued confidence in the company.
• The holding is for investment purposes in the ordinary course of business, suggesting a long-term view rather than activist intent.

Negatives

• The filing does not contain any negative information regarding Anterix Inc. or BlackRock's investment.

Risks

• The filing states that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, which mitigates a potential risk of activist investor intervention.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Anterix Inc.'s future performance or BlackRock's investment strategy beyond the ordinary course of business.

Management Comments

• BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of Anterix Inc.

Industry Context

This filing indicates continued institutional interest in Anterix Inc. from one of the world's largest asset managers, BlackRock. Such a significant stake from a passive investor like BlackRock often signals a belief in the long-term value and stability of the company within its sector, without implying any active management or strategic changes.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: The continued significant stake by BlackRock may instill confidence among existing and potential shareholders, suggesting a belief in the company's long-term prospects.

Next Steps

• BlackRock, Inc. will continue to monitor its beneficial ownership in Anterix Inc. and file amendments to Schedule 13G as required by SEC regulations if its ownership percentage changes significantly.

Key Dates

Recommendation

The filing indicates a significant and stable institutional investment by BlackRock, suggesting a vote of confidence in Anterix Inc. from a major asset manager. While this is a positive signal, the filing itself does not provide new financial performance data or strategic updates from Anterix Inc. that would warrant a 'buy' or 'sell' recommendation. It primarily confirms an existing, substantial institutional holding, supporting a 'hold' position for investors who already own the stock or are considering it based on other fundamental analysis.

Keywords

Anterix Inc., BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, 03676C100